Professor_Bart (@bart_professor) 's Twitter Profile
Professor_Bart

@bart_professor

Professor Dr Bart Van Wijmeersch
Neurologist, Immunologist
#MultipleSclerosis Expert
@ University MS Centre, Hasselt-Pelt, Belgium

ID: 1109554254979743744

calendar_today23-03-2019 20:35:23

1,1K Tweet

2,2K Takipçi

839 Takip Edilen

Luca Bollo (@bollo_luca) 's Twitter Profile Photo

Excited to have just presented at #ECTRIMS2024 our work showing that thalamic atrophy at baseline predicts PIRA in early-MS. These patients show microstructural damage in the thalamus near the ventricle, supporting CSF-mediated damage hypothesis. Cemcat Angela Vidal-Jordana

Excited to have just presented at #ECTRIMS2024 our work showing that thalamic atrophy at baseline predicts PIRA in early-MS. 

These patients show microstructural damage in the thalamus near the ventricle, supporting CSF-mediated damage hypothesis.

<a href="/cemcat_em/">Cemcat</a> <a href="/AVidalJordana/">Angela Vidal-Jordana</a>
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Müller Jannis: MSBase register study in de-escalation of treatment in #MS. Increased risk of relapse reoccurring remains 2.3x higher. No real cutoff for age, EDDS, disease duration or time from last relapse was found. Note: Most were on natalizumab in this study! #ECTRIMS2024

Müller Jannis: MSBase register study in de-escalation of treatment in #MS. 
Increased risk of relapse reoccurring remains 2.3x higher.
No real cutoff for age, EDDS, disease duration or time from last relapse was found.
Note: Most were on natalizumab in this study!
#ECTRIMS2024
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Abdelhak: effect of fingolimod and anti-CD20 treatment on sGFAP (z-scores) evolution & subsequent effect on PIRA in RRMS pts. Lowering Z-GFAP in first two years of treatment decreases PIRA risk in subsequent years by 44 (aCD20)-55%(fingo) sNFL does not add effect #ECTRIMS2024

Abdelhak: effect of fingolimod and anti-CD20 treatment on sGFAP (z-scores) evolution &amp; subsequent effect on PIRA in RRMS pts.
Lowering Z-GFAP in first two years of treatment decreases PIRA risk in subsequent years by 44 (aCD20)-55%(fingo) sNFL does not add effect
#ECTRIMS2024
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Kowalec (US) effect of genetic predisposition for depression on disease activity in #MS. Higher risk of relapse and EDSS progression in persons with higher predisposition for depression! Importance of comorbidity on MS disease course! #ECTRIMS2024

Kowalec (US) effect of genetic predisposition for depression on disease activity in #MS.
Higher risk of relapse and EDSS progression in persons with higher predisposition for depression! 
Importance of comorbidity on MS disease course!
#ECTRIMS2024
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Chataway (UK): MS-stat2 study on simvastatin 80mg vs placebo in SPMS. Large phase 3 trial, unfortunately no significant effect on confirmed progression 🤷🏻‍♂️ #ECTRIMS2024

Chataway (UK): MS-stat2 study on simvastatin 80mg vs placebo in SPMS.
Large phase 3 trial, unfortunately no significant effect on confirmed progression 🤷🏻‍♂️
#ECTRIMS2024
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Jiwon Oh (US): tolebrutinib vs teriflunimode in RRMS (GEMINI trials). - ARR : no difference! - 6m CDW: 29% reduction on tolebr - 3m CDW: 27% reduction on tolebr - New Gd+ lesions are higher on tolebrutinib! - T2 lesions: no difference - good safety profile #ECTRIMS2024

Jiwon Oh (US): tolebrutinib vs teriflunimode in RRMS (GEMINI trials).
- ARR : no difference!
- 6m CDW: 29% reduction on tolebr
- 3m CDW: 27% reduction on tolebr
- New Gd+ lesions are higher on tolebrutinib!
- T2 lesions: no difference 
- good safety profile
#ECTRIMS2024
Barry Singer MD 🧠 (@drbarrysinger) 's Twitter Profile Photo

Lebrun-Frenay: Preventive healthcare in multiple sclerosis will need to focus on lifestyle and Epstein-Barr vaccination. #ECTRIMS2024

Lebrun-Frenay: Preventive healthcare in multiple sclerosis will need to focus on lifestyle and Epstein-Barr vaccination. #ECTRIMS2024
Professor_Bart (@bart_professor) 's Twitter Profile Photo

Ook voor #ectrims2024 Dag 3 overloop en verduidelijk ik kort de belangrijkste topics (met een mooie afsluiter) in een korte video. youtu.be/ULSfrX42W4k?si…

ECTRIMS (@ectrims) 's Twitter Profile Photo

Professor Giancarlo Comi stressed the importance of listening to individuals with MS, pointing out that their experiences are a crucial tool in assessing disease progression. Read ECTRIMS’ tribute to his extraordinary legacy 👉 bit.ly/3B1xFFc #MSResearch #Neurology

Professor Giancarlo Comi stressed the importance of listening to individuals with MS, pointing out that their experiences are a crucial tool in assessing disease progression. Read ECTRIMS’ tribute to his extraordinary legacy 👉 bit.ly/3B1xFFc

#MSResearch #Neurology
Professor_Bart (@bart_professor) 's Twitter Profile Photo

What a big legacy, what a great researcher, what a great teacher, what a great visionary, what a great man… a true example and inspiration. We will miss you dearly. RIP 😔